• 제목/요약/키워드: Pharmacopoeia

검색결과 185건 처리시간 0.022초

염산부플로메딜 정과 염산티클로피딘 정의 용출시험법 개발 (Development of Dissolution Test Method for Buflomedil Hydrochloride Tablets and Ticlopidine Hydrochloride Tablets)

  • 이륜경;정경록;오현숙;심지연;서상철;이효정;김민아;박성민;이규하;손경희;김인규;사홍기;최후균;조태용;홍충만
    • 약학회지
    • /
    • 제56권4호
    • /
    • pp.211-216
    • /
    • 2012
  • Drug dissolution test has been used for the purpose of both quality control of solid oral dosage forms and predicting in vivo drug release profiles. In this study, the dissolution profiles of buflomedil hydrochloride tablets and ticlopidine hydrochloride tablets were investigated according to the "Guidelines on Specifications of Dissolution tests for Oral dosage forms" of Korean Pharmacopoeia (KP). The analytical method using HPLC was validated. The validation was performed in terms of specificity, linearity, accuracy, precision and limit of quantitation.

HPLC/DAD를 이용한 대황의 Sennoside A와 Rhaponticin 동시분석 (The Simultaneous Analysis of Sennoside A and Rhaponticin in Rhei Rhizoma using Liquid Chromatography-Diode Array Detecter)

  • 김욱희;곽재은;정삼주;김동규;한은정;한창호;김복순;최병현;김민영
    • 약학회지
    • /
    • 제54권1호
    • /
    • pp.39-48
    • /
    • 2010
  • The objective of this study was to analyze sennoside A and rhaponticin simultaneously according to sennoside A of Rhei Rhizoma determination in Korean Pharmacopoeia. $NaHCO_3$ solution in KP was compared with methanol which usually used as solution to extract rhaponticin in Rhei Rhizoma. The method was validated through the guidelines of linearity, LOD, LOQ, specificity and accuracy. Two solution weren't different about validation parameter and passed. So this method were applied to the determination of 6 commercial Rhei Rhizoma samples and 2 samples were suitable for the legal standards.

HPLC를 이용한 시판 아테놀롤 원료 및 제품 중 유연물질의 분석 (Analysis of Related Compounds from Commercial Atenolol Raw Materials and Preparations by High-Performance Liquid Chromatography)

  • 뉴엔탄동;강지연;정영희;임은희;황기서;강찬순;김은정;강종성
    • Journal of Pharmaceutical Investigation
    • /
    • 제34권6호
    • /
    • pp.453-457
    • /
    • 2004
  • Atenolol and related compounds found in raw materials and commercial products were analyzed by reversed-phase high-performance liquid chromatography. A mixed solution of phosphate buffer (3.4 g/l, pH 3.0), tetrahydrofurane and methanol (800:20:180, v/v/v) including sodium octanesulfonate (1 g/l) and tetrabutylammonium-hydrogensulfate (0.4 g/l) was used as mobile phase at the flow rate of 0.25 ml/min. Detection was carried out at UV 226 nm. Atenolol related compounds, such as bis ether, tertiary amine and blocker acid were identified by comparing the retention time of the standard. The within-day and between-day precisions of the separated compounds were less than 1.2% and 3.4%, respectively. The contents of related compounds of the tested samples were under the limit prescribed in the European Pharmacopoeia. The pattern of the related compounds showed that atenolol raw materials and products could be classified in three different groups, indicating that the materials originated from different source or treated in different way.

첨가제의 배합목적 재정비와 제형에 따른 첨가제의 범위 (Reconstruction on Application Category of Pharmaceutical Additives and Boundaries of Pharmaceutical Additives according to the Dosage Forms)

  • 조정원;김승수;조원경;박효민;박인숙;정주연;정상전;이선희;황성주
    • Journal of Pharmaceutical Investigation
    • /
    • 제37권6호
    • /
    • pp.403-411
    • /
    • 2007
  • The importance of pharmaceutical additives is increasing and the sorts and application categories are being classified in detail. International pharmaceutical council based on IPEC-America, IPEC-Europe and JPEC was established for specifications, safety and efficacy, approval regulations of pharmaceutical additives in 1992. Therefore, scrutinized examination of pharmaceutical additives used for already approved domestic drug was performed under the supervision of KFDA and nomenclature on application categories of pharmaceutical additives was summarized and endowed their glossary. Additionally, the boundaries of pharmaceutical additives according to the dosage forms based on the principle of the dosage forms of Korean pharmacopoeia were classified. These informations could be available for standards & experimental methods, approval, evaluation, audit of drug and contribution for national welfare.

산초(山椒)의 기원(基原)식물과 이물 규격에 관한 연구 (Study on Original Plants of and Foreign Materials Compliance Guidelines for Zanthoxyli Pericarpium)

  • 이영종
    • 대한본초학회지
    • /
    • 제31권6호
    • /
    • pp.11-20
    • /
    • 2016
  • Objectives : This study aims to examine validity of the following guideline for Zanthoxyli Pericarpium in the Korean Pharmacopoeia regarding foreign materials: "the seeds of Zanthoxyli Pericarpium that are mixed should not exceed 20%." Methods : Varied compliance guidelines for and original plants of Zanthoxyli Pericarpium across countries were compared and contrasted. In order to do this, pharmacopoeias from a number of different countries including Korea were used as references. Results : The weights including seed parts were Z. piperitum 3.48g, Z. schinifolium 2.94g, and Z. bungeanum 2.16g; while the weights of peel parts were Z. piperitum 1.45g, Z. schinifolium 1.69g, and Z. bungeanum 0.98g. In terms of weight, Z. piperitum was the heaviest with its entire part including the seed, whereas Z. schinifolium was the heaviest with its peel part. The proportions of each seed in the whole part were Z. piperitum 58.33%, Z. schinifolium 42.52%, and Z. bungeanum 54.63%. Considering these figures, including seed parts in the guideline up to 20% is inappropriate; however, this guideline is inevitable in order to use seed parts for medicinal purpose. Conclusion : In this article, the author argues if any changes were to made on the guideline for Zanthoxyli Pericarpium with respect to foreign materials - "the seeds of Zanthoxyli Pericarpium that are mixed should not exceed 20%" - its seed part should firsthand be separated from its peel part and be designated as one kind of medicine. Then, revisions on the foreign materials compliance guidelines for Zanthoxyli Pericarpium should also be made.

Deep Learning for Herbal Medicine Image Recognition: Case Study on Four-herb Product

  • Shin, Kyungseop;Lee, Taegyeom;Kim, Jinseong;Jun, Jaesung;Kim, Kyeong-Geun;Kim, Dongyeon;Kim, Dongwoo;Kim, Se Hee;Lee, Eun Jun;Hyun, Okpyung;Leem, Kang-Hyun;Kim, Wonnam
    • 한국자원식물학회:학술대회논문집
    • /
    • 한국자원식물학회 2019년도 추계학술대회
    • /
    • pp.87-87
    • /
    • 2019
  • The consumption of herbal medicine and related products (herbal products) have increased in South Korea. At the same time the quality, safety, and efficacy of herbal products is being raised. Currently, the herbal products are standardized and controlled according to the requirements of the Korean Pharmacopoeia, the National Institute of Health and the Ministry of Public Health and Social Affairs. The validation of herbal products and their medicinal component is important, since many of these herbal products are composed of two or more medicinal plants. However, there are no tools to support the validation process. Interest in deep learning has exploded over the past decade, for herbal medicine using algorithms to achieve herb recognition, symptom related target prediction, and drug repositioning have been reported. In this study, individual images of four herbs (Panax ginseng C.A. Meyer, Atractylodes macrocephala Koidz, Poria cocos Wolf, Glycyrrhiza uralensis Fischer), actually sold in the market, were achieved. Certain image preprocessing steps such as noise reduction and resize were formatted. After the features are optimized, we applied GoogLeNet_Inception v4 model for herb image recognition. Experimental results show that our method achieved test accuracy of 95%. However, there are two limitations in the current study. Firstly, due to the relatively small data collection (100 images), the training loss is much lower than validation loss which possess overfitting problem. Secondly, herbal products are mostly in a mixture, the applied method cannot be reliable to detect a single herb from a mixture. Thus, further large data collection and improved object detection is needed for better classification.

  • PDF

HMG-CoA Reductase Inhibitor인 Pravastatin의 생산성 향상 (Improving Productivity of Pravastatin, HMG-CoA Reductase Inhibitor)

  • 전동수;배동훈
    • 산업식품공학
    • /
    • 제13권4호
    • /
    • pp.243-250
    • /
    • 2009
  • 프라바스타틴 나트륨은 HMG-CoA(3-hydroxy-3-methylglutaryl coenzyme A) 환원효소 저해제로서, 콜레스테롤 생합성의 초기 율속단계(rate-limiting step)에 작용하여 메 발로네이트(mevalonate)의 합성을 저해하는 광범위한 고지혈증 치료제이다. 본 연구에서는 효율적 발효와 고품질의 정제를 통한 생산성 향상을 위해 수행하였다. 프라바스타틴 나트륨의 경쟁력있는 생산성 향상을 위하여 Streptomyces carbophilus KCCM 10370을 UV 돌연변이 처리하여 프라바스타틴 나트륨의 생산량을 약 45배 향상시키는 S. carbophilus K-212(KCCM 10370) 선별하였다. 생산성을 극대화시키기 위하여 콤팩틴 나트륨의 연속식 투입이 회분식 투입보다 생산량이 24%, 전환율 4.3%로 향상 되었으며, 본배양에서 콤팩틴 나트륨의 농도를 연속적으로 투입하여 0.1%(w/v) 이하로 유지시켜 프라바스타틴 나트륨의 생산량이 0.49%, 전환율 70%로 확인하였다. 발효가 종료된 후 배양액을 Diaion HP20 수지 컬럼, 분배(Partition), 그리고 ODS(Octa-Decylsilyl Silicagel) 수지 컬럼 크로마토 그래피를 하여 유럽약전기준(EP)에 적합한 순도 99.7% 이상, 70~72%의 수율이었다. 프라바스타틴 나트륨을 적외부스펙트럼측정법, 자외부스펙트럼측정법, 수소핵자기공명스펙트럼측정법 및 탄소핵자기공명스펙트럼측정법으로 분석한 결과 유럽약전기준(EP)과 일치하였다.

《상한론(傷寒論)》에서 환제의 크기와 복용방법 (The Size and Administration Method of Pill preparation in Treatise on Cold Damage Diseases)

  • 김인락
    • 대한본초학회지
    • /
    • 제36권1호
    • /
    • pp.51-57
    • /
    • 2021
  • Objects : In this study, I aimed to determine the size and administration Method of pills preparation in Treatise on Cold Damage Diseases. Methods : I investigated the Treatise on Cold Damage Diseases, Newly Revised Materia Medica, Variorum of the Classic of Materia Medica, The Korean Herbal Pharmacopoeia, and recent studies. Results : There were four kinds of pills preparation. Each size of pill preparation was equal to the Odongja, Tanwhan, Yolk, and quarter of daily dosage of Decoction. One pill of Tanwhan was equivalent to 16 pills of Odongja, and one Yolk was equal to 40 pills of Odongja. The Diameter of Odongja was 6.5 mm, Tanwhan was 16.37897 mm, and Yolk was 22.11484 mm. Jeodangwhan was equal to one quarter daily dosage of Jeodangtang. Maximum size to swallow with water was Odongja and daily dosage, which was 16 pills, includes one square-inch-spoon of powder preparation. When we made the pill preparation, it is difficult to make 16 pills using one square-inch-spoon of powder. Therefore, Zhang Zhongjing made one dosage started from 10 pills to 20 pills to find out optimum dose. Due to the difficulty of making precise size of pills and considerable amount of daily dosage, there was no smaller size than Odongja. When the size of Pill preparation was larger than Odongja, it was ground or boiled slightly to make suspensions. Conclusions : These results suggest that the sizes of Pill preparation in the Treatise on Cold Damage Diseases were true compared with reality.

백출(Atractylodis Rhizoma Alba)의 품질평가를 위한 지표성분 분석법 평가 (Development of HPLC Method for Quality Assessment of Marker Components in Atractylodis Rhizoma Alba)

  • 이재웅;김준희;강병만;안병관
    • 한국자원식물학회지
    • /
    • 제34권1호
    • /
    • pp.52-58
    • /
    • 2021
  • 백출의 기원 감별 및 품질기준 설정을 위하여 atractylenolide III과 atracylodin을 지표성분으로 설정하였다. HPLC를 이용하여 선정된 지표물질인 atractylenolide III과 atracylodin의 특이성, 직선성, 범위, 검출한계, 정량한계, 정확성, 정밀성에 대한 평가를 실시한 결과 모두 양호한 결과가 나타나 분석법에 문제는 없었으며, 백출과 창출을 각각 분석한 결과 위품인 창출에서만 atracylodin이 검출이 되어 위품 구별이 가능한 지표물질로 손색이 없었다.

중약주사제 실태현황 분석을 통한 국내 약침 연구 방향 모색 (A Study on the Direction of Research for Pharmacopuncture through the Analysis on the Current Status of Chinese Herbal Injections)

  • 황지혜;최수현;송호섭
    • Korean Journal of Acupuncture
    • /
    • 제38권4호
    • /
    • pp.250-266
    • /
    • 2021
  • Objectives : This study was conducted to suggest new alternative methods to improve pharmacopuncture and Korean medicine research by analyzing the injection route, pharmacological effect, and status studies of Chinese herbal injections. Methods : 130 types of marketed and licensed Chinese herbal injection were searched from National Medical Products Administration (NMPA) of China. CNKI, PubMed, EMBASE, and the 2020 edition of the Chinese Pharmacopoeia were used to collect additional information. 'Herbal injection' and 'Chinese herbal injection' were used as keywords. All data were collected mainly on the treatment of Chinese herbal injection. But data which were not related to the relevant research or Chinese herbal injection were excluded. Results : Intramuscular injection accounted for more than half of the single injection route (51%). Acupoint and intramuscular injections accounted for 55% of dual injection routes. Acupoint, intravenous, and intramuscular injections accounted for the largest proportion (76%) of the multiple routes of injections. As for the pharmacological effect, injection for cardiovascular diseases accounted for 29%. About the number of raw herbal materials, single herbal material was the most common. Twelve intervention studies all tested intravenous injections, and half of them investigated cardiocerebrovascular diseases. All were given by intravenous injection. In the side effect section, the most common symptoms were nausea and vomiting. Conclusions : Through the results, it is expected to be used for research and development of new pharmacopuncture and herbal medicine.